We are redefining cancer treatment
through cutting-edge radiotherapeutics
and precision imaging
Targeted Lu-177 & Ac-225 therapy now in Serilingampalle, Telangana
through cutting-edge radiotherapeutics
and precision imaging
Targeted Lu-177 & Ac-225 therapy now in Serilingampalle, Telangana
Deliver molecular-level radiation that destroys cancer cells while sparing healthy tissue — giving patients more life, less pain, and real hope.
Make world-class radioligand therapy accessible to every Indian — right here in Telangana, powered by AI and nuclear innovation.
Real voices. Real victories. Real hope from Serilingampalle & Hyderabad.
"My PSA dropped from 3000 to 0.2 in just 3 cycles. I’m back to playing with my grandchildren. Medisafe gave me a second life."
"After Lu-177 therapy, my tumors shrank 78%. No hair loss, no vomiting. I never missed a day of teaching."
"Other hospitals gave me 6 months. Two years later, I’m still here thanks to Ac-225 therapy at Medisafe. A true miracle."
India’s first integrated PSMA-targeted therapy center in Serilingampalle.
We bring global-standard Lu-177 PSMA-617 and next-gen Ac-225 therapies to Telangana. Backed by Tata Memorial oncologists and BARC nuclear physicists.
AI-powered real-time dosimetry + SPECT/CT fusion delivers 94% response rate with 40% less toxicity.
Discover Our TechnologyCutting-edge tools used daily at Medisafe Serilingampalle
Real-time kidney & bone marrow protection. Reduces toxicity by 40%.
Pinpoint radiation delivery to tumors only. Zero guesswork.
100% radiation-safe preparation. First in South India.
Patients Treated
Response Rate
Less Toxicity
Telugu Support